相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Therapeutic AAV Gene Transfer to the Nervous System: A Clinical Reality
Eloise Hudry et al.
NEURON (2019)
Huntingtin Lowering Strategies for Disease Modification in Huntington's Disease
Sarah J. Tabrizi et al.
NEURON (2019)
Targeting Huntingtin Expression in Patients with Huntington's Disease
Sarah J. Tabrizi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Prevalence of Carriers of Intermediate and Pathological Polyglutamine Disease-Associated Alleles Among Large Population-Based Cohorts
Sarah L. Gardiner et al.
JAMA NEUROLOGY (2019)
Allele-selective transcriptional repression of mutant HTT for the treatment of Huntington's disease
Bryan Zeitler et al.
NATURE MEDICINE (2019)
CAG Repeat Not Polyglutamine Length Determines Timing of Huntington's Disease Onset
Jong-Min Lee et al.
CELL (2019)
A divalent siRNA chemical scaffold for potent and sustained modulation of gene expression throughout the central nervous system
Julia F. Alterman et al.
NATURE BIOTECHNOLOGY (2019)
Patient-Customized Oligonucleotide Therapy for a Rare Genetic Disease
J. Kim et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
A Comprehensive Haplotype-Targeting Strategy for Allele-Specific HTT Suppression in Huntington Disease
Chris Kay et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2019)
AAV5-miHTT Lowers Huntingtin mRNA and Protein without Off-Target Effects in Patient-Derived Neuronal Cultures and Astrocytes
Sonay Keskin et al.
MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT (2019)
Huntington's disease: a clinical review
P. McColgan et al.
EUROPEAN JOURNAL OF NEUROLOGY (2018)
Antisense oligonucleotides: the next frontier for treatment of neurological disorders
Carlo Rinaldi et al.
NATURE REVIEWS NEUROLOGY (2018)
Inotersen Treatment for Patients with Hereditary Transthyretin Amyloidosis
M. D. Benson et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Evaluation of mutant huntingtin and neurofilament proteins as potential markers in Huntington's disease
Lauren M. Byrne et al.
SCIENCE TRANSLATIONAL MEDICINE (2018)
A Fresh Look at Huntingtin mRNA Processing in Huntington's Disease
Lindsay Romo et al.
JOURNAL OF HUNTINGTONS DISEASE (2018)
Validation of a prognostic index for Huntington's disease
Jeffrey D. Long et al.
MOVEMENT DISORDERS (2017)
Contribution of Neuroepigenetics to Huntington's Disease
Laetitia Francelle et al.
FRONTIERS IN HUMAN NEUROSCIENCE (2017)
Motor, cognitive, and functional declines contribute to a single progressive factor in early HD
Scott A. Schobel et al.
NEUROLOGY (2017)
Nusinersen versus Sham Control in Infantile-Onset Spinal Muscular Atrophy
R. S. Finkel et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Is Huntingtin Dispensable in the Adult Brain?
Jeh-Ping Liu et al.
JOURNAL OF HUNTINGTONS DISEASE (2017)
Endoplasmic reticulum stress: The cause and solution to Huntington's disease?
Yuwei Jiang et al.
BRAIN RESEARCH (2016)
Adeno-Associated Virus-Based Gene Therapy for CNS Diseases
Michael Hocquemiller et al.
HUMAN GENE THERAPY (2016)
Neuroimmunology of Huntington's Disease: Revisiting Evidence from Human Studies
Natalia P. Rocha et al.
MEDIATORS OF INFLAMMATION (2016)
The Prevalence of Huntington's Disease
Michael D. Rawlins et al.
NEUROEPIDEMIOLOGY (2016)
Ablation of huntingtin in adult neurons is nondeleterious but its depletion in young mice causes acute pancreatitis
Guohao Wang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)
Design, Characterization, and Lead Selection of Therapeutic miRNAs Targeting Huntingtin for Development of Gene Therapy for Huntington's Disease
Jana Miniarikova et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2016)
Identification of Genetic Factors that Modify Clinical Onset of Huntington's Disease
Jong-Min Lee et al.
CELL (2015)
Quantification of mutant huntingtin protein in cerebrospinal fluid from Huntington's disease patients
Edward J. Wild et al.
JOURNAL OF CLINICAL INVESTIGATION (2015)
Ultrasensitive measurement of huntingtin protein in cerebrospinal fluid demonstrates increase with Huntington disease stage and decrease following brain huntingtin suppression
Amber L. Southwell et al.
SCIENTIFIC REPORTS (2015)
Chorea: A Journey through History
Thiago Cardoso Vale et al.
TREMOR AND OTHER HYPERKINETIC MOVEMENTS (2015)
Personalized gene silencing therapeutics for Huntington disease
C. Kay et al.
CLINICAL GENETICS (2014)
Silencing Mutant Huntingtin by Adeno-Associated Virus-Mediated RNA Interference Ameliorates Disease Manifestations in the YAC128 Mouse Model of Huntington's Disease
Lisa M. Stanek et al.
HUMAN GENE THERAPY (2014)
Six-month partial suppression of Huntingtin is well tolerated in the adult rhesus striatum
Richard Grondin et al.
BRAIN (2012)
Widespread suppression of huntingtin with convection-enhanced delivery of siRNA
David K. Stiles et al.
EXPERIMENTAL NEUROLOGY (2012)
Proteomic Analysis of Wild-type and Mutant Huntingtin-associated Proteins in Mouse Brains Identifies Unique Interactions and Involvement in Protein Synthesis
Brady P. Culver et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
CAG repeat expansion in Huntington disease determines age at onset in a fully dominant fashion
J. -M. Lee et al.
NEUROLOGY (2012)
Huntingtin Holiday: Progress toward an Antisense Therapy for Huntington's Disease
Xiao-Hong Lu et al.
NEURON (2012)
Sustained Therapeutic Reversal of Huntington's Disease by Transient Repression of Huntingtin Synthesis
Holly B. Kordasiewicz et al.
NEURON (2012)
Indexing Disease Progression at Study Entry With Individuals At-Risk for Huntington Disease
Ying Zhang et al.
AMERICAN JOURNAL OF MEDICAL GENETICS PART B-NEUROPSYCHIATRIC GENETICS (2011)
Huntington's disease: from molecular pathogenesis to clinical treatment
Christopher A. Ross et al.
LANCET NEUROLOGY (2011)
Preclinical Safety of RNAi-Mediated HTT Suppression in the Rhesus Macaque as a Potential Therapy for Huntington's Disease
Jodi L. McBride et al.
MOLECULAR THERAPY (2011)
Proteolysis of Mutant Huntingtin Produces an Exon 1 Fragment That Accumulates as an Aggregated Protein in Neuronal Nuclei in Huntington Disease
Christian Landles et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Huntington's disease
Marianne J. U. Novak et al.
BMJ-BRITISH MEDICAL JOURNAL (2010)
Five siRNAs Targeting Three SNPs May Provide Therapy for Three-Quarters of Huntington's Disease Patients
Edith L. Pfister et al.
CURRENT BIOLOGY (2009)
Tetrabenazine as antichorea therapy in Huntington disease - A randomized controlled trial
FJ Marshall et al.
NEUROLOGY (2006)
RNA interference improves motor and neuropathological abnormalities in a Huntington's disease mouse model
SQ Harper et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
A new model for prediction of the age of onset and penetrance for Huntington's disease based on CAG length
DR Langbehn et al.
CLINICAL GENETICS (2004)
Inactivation of Hdh in the brain and testis results in progressive neurodegeneration and sterility in mice
I Dragatsis et al.
NATURE GENETICS (2000)
Reversal of neuropathology and motor dysfunction in a conditional model of Huntington's disease
A Yamamoto et al.
CELL (2000)
分享论文
